Reuters Health Report

Click to View in Browser 12/20/2013 From street stalls to bourses, South East Asia's traditional medicine makers promise panacea JAKARTA/SINGAPORE (Reuters) - On rainy days in Jakarta, a canny street merchant like Emi can sell two dozen sachets of herbal cold cure Tolak Angin to office workers and labourers sniffling by her roadside stall. Ariad to resume sale of leukemia drug Iclusig (Reuters) - Ariad Pharmaceuticals Inc said it will resume selling its leukemia drug, Iclusig, in the United States, nearly two months after sales were halted due to safety concerns. Sanofi faces U.S. class action over MS drug Lemtrada PARIS (Reuters) - A U.S. law firm is launching a class action against France's Sanofi over what it calls misleading statements on the safety and efficacy of its multiple sclerosis drug Lemtrada. Aspirin risks may outweigh benefits in healthy adults NEW YORK (Reuters Health) - Healthy adults who take daily aspirin to stave off heart disease may be inviting more harm than benefit, according to a new review of past studies. Obamacare sign-up deadline expected to bring demand surge, confusion NEW YORK (Reuters) - Americans have only a few more days to sign up for insurance plans created under President Barack Obama's healthcare law to ensure coverage starts on January 1, a deadline that could triple demand and strain enrollment systems. Philip Morris, Altria team up on cigarette alternatives LONDON (Reuters) - Altria Group and Philip Morris International (PMI), the makers of Marlboro cigarettes in the United States and internationally, are teaming up to market electronic cigarettes and other "reduced risk" tobacco products. EU backs J&J's TB drug, postpones decision on Teva MS pill LONDON (Reuters) - European regulators on Friday recommended approval of an innovative tuberculosis drug from Johnson & Johnson but postponed a keenly awaited decision on a new multiple sclerosis pill from Teva Pharmaceutical Industries. California high school to test students for tuberculosis (Reuters) - Some 1,800 students and staff at a southern California high school are to be screened for tuberculosis on Friday, after one pupil was diagnosed with the disease and dozens more may have been infected, health officials said. FDA delays decision on approval for wider use of Amarin's Vascepa (Reuters) - Amarin Corp Plc said the U.S. Food and Drug Administration has informed the company that it would delay a decision on approval of a blood fat-lowering drug for use in a broader patient population. Last-minute Obamacare exemption for those with canceled plans WASHINGTON (Reuters) - The Obama administration made a major last-minute policy shift on Thursday, saying the change would help Americans meet a looming deadline to replace insurance plans canceled because of new standards under Obamacare reforms. Related Video Rudolph's adaptive eyes could pose Christmas problems Sea Shepherd ships prepare for departure The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend